Bharat Immunologicals Market Capitalization vs. Price to Earning

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 21.3  0.1  0.47%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Price to Earning vs. Market Capitalization Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is rated below average in market capitalization category among related companies. It is rated below average in price to earning category among related companies .
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Bharat Immunologicals 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
1.02 B
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Bharat Immunologicals 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
=
(17.66) times
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Comparison

Price to Earning Comparison
Bharat Immunologicals is currently under evaluation in price to earning category among related companies.
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. more
NameBharat Immunologicals Biologicals Corp Ltd
Macroaxis Advice
InstrumentIndia Stock Stocks Directory
ExchangeBombay Stock Exchange
CurrencyINR
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders